Acadia Healthcare Company, Inc. (ACHC) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Acadia Healthcare Company, Inc.'s filing signal turned negative.

Acadia Healthcare Company, Inc. is a leading publicly traded pure-play provider of behavioral healthcare services in the U.S., operating 277 facilities across 40 states and Puerto Rico as of December 31, 2025. The company focuses on high-acuity and complex-needs patients, offering services through acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers. Its growth strategy centers on expanding existing facilities, forming joint venture partnerships, developing de novo facilities, and pursuing acquisitions. Acadia's revenue is primarily derived from government payors, with Medicaid accounting for 57.7% and Medicare for 14.3% in 2025, supplemented by commercial payors (24.6%) and other sources (3.4%).

Revenue is driven by patient services across its various facility types, with primary payment sources being Medicaid, Medicare, and commercial insurers. Growth is achieved through expanding bed capacity, opening new facilities (wholly-owned and joint ventures), and strategic acquisitions.